Lymph Node Biopsy
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Follicular Lymphoma
Follicular Lymphoma What is follicular lymphoma? Let us explain it to you. www.anticancerfund.org www.esmo.org ESMO/ACF Patient Guide Series based on the ESMO Clinical Practice Guidelines FOLLICULAR LYMPHOMA: A GUIDE FOR PATIENTS PATIENT INFORMATION BASED ON ESMO CLINICAL PRACTICE GUIDELINES This guide for patients has been prepared by the Anticancer Fund as a service to patients, to help patients and their relatives better understand the nature of follicular lymphoma and appreciate the best treatment choices available according to the subtype of follicular lymphoma. We recommend that patients ask their doctors about what tests or types of treatments are needed for their type and stage of disease. The medical information described in this document is based on the clinical practice guidelines of the European Society for Medical Oncology (ESMO) for the management of newly diagnosed and relapsed follicular lymphoma. This guide for patients has been produced in collaboration with ESMO and is disseminated with the permission of ESMO. It has been written by a medical doctor and reviewed by two oncologists from ESMO including the lead author of the clinical practice guidelines for professionals, as well as two oncology nurses from the European Oncology Nursing Society (EONS). It has also been reviewed by patient representatives from ESMO’s Cancer Patient Working Group. More information about the Anticancer Fund: www.anticancerfund.org More information about the European Society for Medical Oncology: www.esmo.org For words marked with an asterisk, a definition is provided at the end of the document. Follicular Lymphoma: a guide for patients - Information based on ESMO Clinical Practice Guidelines – v.2014.1 Page 1 This document is provided by the Anticancer Fund with the permission of ESMO. -
Axillary Lymph Nodes in Breast Cancer Patients: Sonographic Evaluation*
Pinheiro DJPCArtigo et al. / deLinfonodos Revisão axilares – avaliação ultrassonográfica Linfonodos axilares em pacientes com câncer de mama: avaliação ultrassonográfica* Axillary lymph nodes in breast cancer patients: sonographic evaluation Denise Joffily Pereira da Costa Pinheiro1, Simone Elias2, Afonso Celso Pinto Nazário3 Pinheiro DJPC, Elias S, Nazário ACP. Linfonodos axilares em pacientes com câncer de mama: avaliação ultrassonográfica. Radiol Bras. 2014 Jul/Ago; 47(4):240–244. Resumo O estadiamento axilar nas pacientes portadoras de câncer de mama inicial é fator essencial no planejamento terapêutico. Atualmente este é realizado durante o tratamento cirúrgico, mas há uma tendência em buscar técnicas pré-operatórias e de menor morbidade para avaliação dos linfonodos axilares. A ultrassonografia é um exame amplamente usado para esta finalidade e muitas vezes associado a punção aspirativa por agulha fina ou por agulha grossa. Entretanto, os critérios ultrassonográficos de suspeição para linfonodos axilares não apresentam valores preditivos significativos, gerando resultados discrepantes em estudos sobre sensibilidade e especificidade do método. O objetivo deste trabalho é realizar uma revisão na literatura médica sobre a ultrassonografia no estadiamento axilar e as principais alterações morfológicas do linfonodo metastático. Unitermos: Câncer de mama; Linfonodos axilares; Ultrassonografia; Aspectos morfológicos. Abstract Axillary staging of patients with early-stage breast cancer is essential in the treatment planning. Currently such staging is intraoperatively performed, but there is a tendency to seek a preoperative and less invasive technique to detect lymph node metastasis. Ultrasonography is widely utilized for this purpose, many times in association with fine-needle aspiration biopsy or core needle biopsy. However, the sonographic criteria for determining malignancy in axillary lymph nodes do not present significant predictive values, producing discrepant results in studies evaluating the sensitivity and specificity of this method. -
Impact of the Number of Dissected Axillary Lymph Nodes on Survival
ISSN: 2643-4563 Nabil et al. Int J Oncol Res 2019, 2:015 DOI: 10.23937/2643-4563/1710015 Volume 2 | Issue 1 International Journal of Open Access Oncology Research RESEARCH ARTICLE Impact of the Number of Dissected Axillary Lymph Nodes on Survival in Breast Cancer Patients Emad Eldin Nabil1, Ahmed M Maklad2,3, Ashraf Elyamany4,5*, Emad Gomaa6 and Moamen M Ali3,7 1Clinical Oncology and Nuclear Medicine Department, Sohag University Hospitals, Egypt 2Clinical Oncology and Nuclear Medicine Department, Sohag University Hospitals, Egypt 3King Fahad Medical City, Riyadh, KSA 4 Medical Oncology Department, SECI, Assiut University, Egypt Check for updates 5King Saud Medical City, Riyadh, KSA 6General Surgery Department, Sohag University Hospitals, Egypt 7Medical Physics, Radiation Oncology Department, SECI, Assiut University, Egypt *Corresponding author: Ashraf Elyamany, Medical Oncology Department, SECI, Assiut University, Egypt; King Saud Medical City, Riyadh, KSA Abstract regard median OS for patients having more than 10 LN excised was for N0, N1, N2, N3 5.57, 5.94, 4.97, 4.61 years Background: For patients with breast cancer, axillary dis- respectively while in the other group having less than 10 LN section was a standard treatment, especially with patient excised OS was 5.4, 5.14, 5.14 years respectively with P = with positive metastases in the sentinel nodes. For some 0.117. Regarding Lymphedema There was highly significant patients axillary dissection might be over-treatment, includ- difference between both arms p value 0.000, with higher ing those who have had a mastectomy. Especially with grades in arm I (moderate 17 cases and 6 cases severe the new trend of many radiation-therapy centers, provide edema). -
M. H. RATZLAFF: the Superficial Lymphatic System of the Cat 151
M. H. RATZLAFF: The Superficial Lymphatic System of the Cat 151 Summary Four examples of severe chylous lymph effusions into serous cavities are reported. In each case there was an associated lymphocytopenia. This resembled and confirmed the findings noted in experimental lymph drainage from cannulated thoracic ducts in which the subject invariably devdops lymphocytopenia as the lymph is permitted to drain. Each of these patients had com munications between the lymph structures and the serous cavities. In two instances actual leakage of the lymphography contrrult material was demonstrated. The performance of repeated thoracenteses and paracenteses in the presenc~ of communications between the lymph structures and serous cavities added to the effect of converting the. situation to one similar to thoracic duct drainage .The progressive immaturity of the lymphocytes which was noted in two patients lead to the problem of differentiating them from malignant cells. The explanation lay in the known progressive immaturity of lymphocytes which appear when lymph drainage persists. Thankful acknowledgement is made for permission to study patients from the services of Drs. H. J. Carroll, ]. Croco, and H. Sporn. The graphs were prepared in the Department of Medical Illustration and Photography, Dowristate Medical Center, Mr. Saturnino Viloapaz, illustrator. References I Beebe, D. S., C. A. Hubay, L. Persky: Thoracic duct 4 Iverson, ]. G.: Phytohemagglutinin rcspon•e of re urctcral shunt: A method for dccrcasingi circulating circulating and nonrecirculating rat lymphocytes. Exp. lymphocytes. Surg. Forum 18 (1967), 541-543 Cell Res. 56 (1969), 219-223 2 Gesner, B. M., J. L. Gowans: The output of lympho 5 Tilney, N. -
December 2020 E-Tips Solid Tumor Rules
New Jersey State Cancer Registry December 2020 E-Tips Cancer Epidemiology Services http://www.nj.gov/health/ces (609) 633-0500 Solid Tumor Rules: December 2020 Update ICD-0-3.2 changes have also been added to applicable site modules. Most changes are minor: terminology, additional definitions, new notes and examples. In order to clarify histology coding instructions, new rules have been added and histology tables updated. These updates do not require review of already abstracted cases. The December 2020 rules replace the current rules and should be used now. SEER Strongly recommends reading the December 2020 Change Log to understand what changes were made. The updated Solid Tumor Rules may be accessed at: https://seer.cancer.gov/tools/solidtumor/ Reportability Changes for 2021 Radiation Coding Total Dose (1533) Starting 01/01/2021 the following terms are reportable: If doses across phases to a single point of region, code Sum of all phases. ** (see 2019 update below) Early or evolving melanoma in situ, or any other early or If doses are to multiple metastatic sites, code highest evolving melanoma, are reportable. dose site. If doses are to primary site and metastatic site, code dose All GIST tumors are reportable and classified as 8936/3 in from the primary site only. ICD-O-3.2. When you have two different sites, you cannot add the Nearly all thymomas are reportable; the exceptions are doses together to get the total dose. microscopic thymoma or thymoma benign (8580/0), micronodular thymoma with lymphoid stroma (8580/1), Radiation Tips and updates for 2019 and ectopic hamartomatous thymoma (8587/0). -
Lymphatic Drainage of the Breast: from Theory to Surgical Practice
Int. J. Morphol., 27(3):873-878, 2009. Lymphatic Drainage of the Breast: from Theory to Surgical Practice Drenaje Linfático de la Mama: desde la Teoría a la Práctica Quirúrgica *José Humberto Tavares Guerreiro Fregnani & **José Rafael Macéa FREGNANI, J. H. T. G. & MACÉA, J. R. Lymphatic drainage of the breast: from theory to surgical practice. Int. J. Morphol., 27(3):873-878, 2009. SUMMARY: Until recently, complete removal of axillary lymph nodes was performed as part of the treatment of breast cancer. Sentinel lymph node biopsy (SLNB) in selected cases has reduced the number of cases of wide axillary dissection and the related morbidity. Knowledge of breast lymphatic drainage is essential for understanding the principles behind SLNB and also for performing safe and correct axillary lymphonodectomy. This paper describes in detail the anatomical issues relating to breast lymphatic drainage and the correlated axillary and extra-axillary lymph nodes. In addition, it shows the application of this theoretical knowledge to surgical practice, especially with regard to SLNB and lymphonodectomy. The surgical nomenclature is compared with the current International Anatomical Terminology. KEY WORDS: Lymphatic drainage, Sentinel lymph node biopsy, Breast cancer. INTRODUCTION Breast cancer is the most frequent type of tumor changes to the sensitivity of the upper limb, posterior scapular among women, accounting for approximately one quarter dislocation (winged scapula syndrome), brachial plexus of all tumors in women. It has been estimated that more than lesions, axillary vessel thrombosis and lesions, skin necrosis one million new cases occur worldwide annually. Breast and pectoral muscle atrophy, among others (Torresan et al., cancer is responsible for significant morbidity and mortality 2002; Kim et al., 2006). -
About Mastectomy and Sentinel Lymph Node Biopsy
All About Mastectomy and Sentinel Lymph Node Biopsy One of the most important goals of Moffitt Cancer Center is to provide you with quality patient care through education, research and patient care. The following information has been developed to help you understand the mastectomy and sentinel lymph node biopsy procedures for which you have been scheduled. Members of your health care team will review this information with you and answer any questions that you may have. Definitions: Mastectomy – Removal of the entire breast but not the muscles underneath. Lymph Nodes - Small bean shaped glands found in the armpit. They remove waste and fluids from the arm and breast and help fight infection. They are also call lymph glands. Sentinel Lymph Node - The first place breast cancer may metastasize (or spread) is to lymph nodes in the axilla (underarm area) on the side of the body where the cancer is. The first lymph node(s) are referred to as the sentinel lymph node(s) or the “gate keepers”. These nodes are first biopsied to determine if the cancer has spread. If cancer cells are not found in the sentinel lymph node(s) that were removed, it will not be necessary to remove the remaining lymph nodes in the arm pit. Sentinel Lymph Node Mapping and Biopsy - This procedure is a two step process. Performing the sentinel lymph node biopsy requires a small incision in your axilla. In the first step, the doctor injects a radioactive substance and/ or blue dye in the area around the tumor. Lymphatic channels (like blood vessels) carry these materials to the sentinel lymph node. -
Consensus Guideline on the Management of the Axilla in Patients with Invasive/In-Situ Breast Cancer
- Official Statement - Consensus Guideline on the Management of the Axilla in Patients With Invasive/In-Situ Breast Cancer Purpose To outline the management of the axilla for patients with invasive and in-situ breast cancer. Associated ASBrS Guidelines or Quality Measures 1. Performance and Practice Guidelines for Sentinel Lymph Node Biopsy in Breast Cancer Patients – Revised November 25, 2014 2. Performance and Practice Guidelines for Axillary Lymph Node Dissection in Breast Cancer Patients – Approved November 25, 2014 3. Quality Measure: Sentinel Lymph Node Biopsy for Invasive Breast Cancer – Approved November 4, 2010 4. Prior Position Statement: Management of the Axilla in Patients With Invasive Breast Cancer – Approved August 31, 2011 Methods A literature review inclusive of recent randomized controlled trials evaluating the use of sentinel lymph node surgery and axillary lymph node dissection for invasive and in-situ breast cancer as well as the pathologic review of sentinel lymph nodes and indications for axillary radiation was performed. This is not a complete systematic review but rather, a comprehensive review of recent relevant literature. A focused review of non-randomized controlled trials was then performed to develop consensus guidance on management of the axilla in scenarios where randomized controlled trials data is lacking. The ASBrS Research Committee developed a consensus document, which was reviewed and approved by the ASBrS Board of Directors. Summary of Data Reviewed Recommendations Based on Randomized Controlled -
Anatomy and Physiology in Relation to Compression of the Upper Limb and Thorax
Clinical REVIEW anatomy and physiology in relation to compression of the upper limb and thorax Colin Carati, Bren Gannon, Neil Piller An understanding of arterial, venous and lymphatic flow in the upper body in normal limbs and those at risk of, or with lymphoedema will greatly improve patient outcomes. However, there is much we do not know in this area, including the effects of compression upon lymphatic flow and drainage. Imaging and measuring capabilities are improving in this respect, but are often expensive and time-consuming. This, coupled with the unknown effects of individual, diurnal and seasonal variances on compression efficacy, means that future research should focus upon ways to monitor the pressure delivered by a garment, and its effects upon the fluids we are trying to control. More is known about the possible This paper will describe the vascular Key words effects of compression on the anatomy of the upper limb and axilla, pathophysiology of lymphoedema when and will outline current understanding of Anatomy used on the lower limbs (Partsch and normal and abnormal lymph drainage. It Physiology Junger, 2006). While some of these will also explain the mechanism of action Lymphatics principles can be applied to guide the use of compression garments and will detail Compression of compression on the upper body, it is the effects of compression on fluid important that the practitioner is movement. knowledgeable about the anatomy and physiology of the upper limb, axilla and Vascular drainage of the upper limb thorax, and of the anatomical and vascular It is helpful to have an understanding of Little evidence exists to support the differences that exist between the upper the vascular drainage of the upper limb, use of compression garments in the and lower limb, so that the effects of these since the lymphatic drainage follows a treatment of lymphoedema, particularly differences can be considered when using similar course (Figure 1). -
Application of Preoperative Computed Tomographic Lymphography For
Wen et al. BMC Surg (2021) 21:187 https://doi.org/10.1186/s12893-021-01190-7 RESEARCH ARTICLE Open Access Application of preoperative computed tomographic lymphography for precise sentinel lymph node biopsy in breast cancer patients Shishuai Wen1,2,3†, Yiran Liang1†, Xiaoli Kong1, Baofeng Liu4, Tingting Ma1, Yeqing Zhou1, Liyu Jiang1, Xiaoyan Li1 and Qifeng Yang1,5,6* Abstract Background: In light of the extensive application of sentinel lymph node biopsy (SLNB) in clinically node-negative breast cancer patients and the recently investigated failure of SLNB after lumpectomy, it has become important to explore methods for preoperative mapping of sentinel lymph nodes (SLNs) and their lymphatics to direct precise SLNB and improve the identifcation rate of SLNs. Methods: Twenty-seven patients with suspected breast cancer based on the results of the clinical examination and imaging were enrolled in the study. Computed tomographic lymphography (CTLG) followed by CT three-dimensional reconstruction was performed to determine the localization of SLNs and lymphatics on the body surface preopera- tively. Intraoperatively combined staining with methylene blue and indocyanine green was used to evaluate the accuracy and feasibility of CTLG. Results: SLNs and lymphatics from the breast were identifed using CTLG in all patients, and preoperative SLNs and lymphatics localization on the body surface showed a signifcant role in the selection of operative incision and injec- tion points. The accuracy rate of SLN and lymphatic detection by CTLG was 92.6% compared with intraoperatively combined staining. Moreover, preoperative CTLG performed well in SLN number detection, and the accuracy rate was 95.2%. Conclusion: We evaluate the procedure and application of preoperative CTLG in the superfcial localization of SLNs and lymphatics, which may lead to a decreased incidence of cutting of the lymphatics of SLNs and consequently more rapid and accurate SLN detection. -
Update on Sentinel Lymph Node Biopsy in Surgical Staging of Endometrial Carcinoma
Journal of Clinical Medicine Review Update on Sentinel Lymph Node Biopsy in Surgical Staging of Endometrial Carcinoma Ane Gerda Z Eriksson 1,2,* , Ben Davidson 2,3, Pernille Bjerre Trent 1,2, Brynhildur Eyjólfsdóttir 1, Gunn Fallås Dahl 1, Yun Wang 1 and Anne Cathrine Staff 2,4 1 Department of Gynecologic Oncology, Oslo University Hospital, Norwegian Radium Hospital, N-0310 Oslo, Norway; [email protected] (P.B.T.); [email protected] (B.E.); [email protected] (G.F.D.); [email protected] (Y.W.) 2 Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, N-0316 Oslo, Norway; [email protected] (B.D.); [email protected] (A.C.S.) 3 Department of Pathology, Oslo University Hospital, Norwegian Radium Hospital, N-0310 Oslo, Norway 4 Division of Obstetrics and Gynaecology, Oslo University Hospital, Ullevål, N-0424 Oslo, Norway * Correspondence: [email protected] Abstract: Sentinel lymph node (SLN) biopsy has emerged as an alternative staging approach in women with assumed early-stage endometrial carcinoma. Through image-guided surgery and pathologic ultrastaging, the SLN approach is introducing “precision medicine” to the surgical management of gynecologic cancers, providing a comprehensive evaluation of high-yield lymph nodes. This approach improves the surgeons’ ability to detect small-volume metastatic disease while reducing intraoperative and postoperative morbidity associated with lymphadenectomy. Although the majority of clinicians in Europe and the USA have recognized the value of SLN biopsy in endometrial carcinoma and introduced this as part of clinical practice, there is ongoing debate Citation: Eriksson, A.G.Z; Davidson, regarding its role in very low-risk patients as well as in patients at high risk of nodal metastasis. -
Having a Sentinel Lymph Node Biopsy
Having a sentinel lymph node biopsy The aim of this leaflet is to answer questions you may have about a sentinel lymph node (SLN) biopsy. The leaflet explains what the surgical procedure involves and the benefits and risks of having it. If you have any further questions or concerns, please feel free to speak to a member of your hospital team who would be happy to help. What is a sentinel lymph node biopsy? A biopsy is when a sample of tissue is taken and looked at under a microscope. An SLN biopsy is a surgical procedure to remove one or more of the nodes (glands) from under your arm (axilla) into which the lymph fluid from the breast first drains. These are then examined under a microscope to see if there are any breast cancer cells present. What is the lymphatic system? The lymphatic system is a system of channels in your body, which drains fluid from your body tissues. It plays an important part in keeping your blood clean and fighting infection. Breast cancer cells can spread through these channels. Lymph is a milky fluid and is rich in the white cells, which help us fight infections. It circulates around your body by passing through tiny, then larger vessels and lymph nodes (glands). Each area of the body will drain lymph fluid into certain nodes, usually to the group of nodes which is closest. In the breast this group is usually in the armpit. The first node the fluid drains in to is called the sentinel lymph node.